BlackRock Health Sciences Trust (NYSE:BME) Stock Crosses Above 50-Day Moving Average – What’s Next?

BlackRock Health Sciences Trust (NYSE:BME)’s share price passed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $41.35 and traded as high as $42.35. BlackRock Health Sciences Trust shares last traded at $41.76, with a volume of 28,236 shares.

BlackRock Health Sciences Trust Price Performance

The firm has a 50 day moving average price of $41.36 and a two-hundred day moving average price of $38.87.

BlackRock Health Sciences Trust Announces Dividend

The firm also recently announced a monthly dividend, which will be paid on Tuesday, March 31st. Investors of record on Friday, March 13th will be given a dividend of $0.2621 per share. The ex-dividend date is Friday, March 13th. This represents a c) annualized dividend and a dividend yield of 7.5%.

Institutional Investors Weigh In On BlackRock Health Sciences Trust

A number of large investors have recently bought and sold shares of the stock. Northwestern Mutual Wealth Management Co. increased its position in shares of BlackRock Health Sciences Trust by 22.2% during the third quarter. Northwestern Mutual Wealth Management Co. now owns 1,417 shares of the company’s stock worth $53,000 after acquiring an additional 257 shares in the last quarter. AlphaStar Capital Management LLC raised its stake in shares of BlackRock Health Sciences Trust by 2.2% in the fourth quarter. AlphaStar Capital Management LLC now owns 12,099 shares of the company’s stock worth $498,000 after purchasing an additional 258 shares during the last quarter. Oppenheimer & Co. Inc. lifted its holdings in shares of BlackRock Health Sciences Trust by 5.9% in the third quarter. Oppenheimer & Co. Inc. now owns 6,715 shares of the company’s stock valued at $250,000 after purchasing an additional 373 shares in the last quarter. SOA Wealth Advisors LLC. boosted its position in shares of BlackRock Health Sciences Trust by 20.3% during the third quarter. SOA Wealth Advisors LLC. now owns 2,780 shares of the company’s stock valued at $103,000 after buying an additional 469 shares during the last quarter. Finally, Royal Bank of Canada grew its holdings in BlackRock Health Sciences Trust by 0.5% during the first quarter. Royal Bank of Canada now owns 143,546 shares of the company’s stock worth $5,546,000 after buying an additional 684 shares in the last quarter.

About BlackRock Health Sciences Trust

BlackRock Health Sciences Trust (NYSE: BME) is a closed-end management investment company that seeks long-term total return through a combination of dividend income and capital appreciation. Managed by BlackRock Fund Advisors, the trust invests primarily in the equity securities of domestic and international issuers engaged in the health sciences sector. The portfolio typically includes common stocks, corporate bonds and convertible securities of companies involved in biotechnology, pharmaceuticals, medical devices and healthcare services.